Bill Ackman Supports Valeant’s Allergan Offer

April 22 (Bloomberg) -- Valeant Pharmaceuticals International offered to buy Allergan in a cash-and-stock deal valued at $45.7 billion that will give the Canadian company the Botox wrinkle treatment. Pershing Square Capital Management LP, the fund run by Bill Ackman, Allergan’s largest shareholder, supports the offer, Valeant said. Stephanie Ruhle reports on Bloomberg Television’s “In The Loop.” (Source: Bloomberg)

Full Show: Bloomberg Businessweek (03/24)
26:12 - Bloomberg Television takes you behind the scenes of our award-winning magazine "Bloomberg Businessweek." Hosts Carol Massar and Oliver Renick talk with the writers who break news on a weekly basis. (Source: Bloomberg)
  • S&P 500 Winners and Losers for 03/24
  • Full Show: Best of Bloomberg Markets Middle East (03/24)
  • How to Trade the Health Care Select Sector SPDR Fund